Fractyl Health, Inc. 是一家代谢治疗公司,开发用于治疗2型糖尿病(T2D)和肥胖症的疗法。该公司总部位于马萨诸塞州列克星敦。
财务指标
营业收入
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
营业支出
2026-06-30
$1909.6万
2026-03-31
$2082万
2025-12-31
$2328.4万
2025-09-30
$2269.4万
净利润
2026-06-30
-$2553.8万
2026-03-31
$921.8万
2025-12-31
-$4372.7万
2025-09-30
-$4560.3万
净利润率
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
每股收益
2026-06-30
$-0.12
2026-03-31
$0.05
2025-12-31
$-0.07
2025-09-30
$-0.71
息税折旧摊销前利润
2026-06-30
-$2526万
2026-03-31
$949.9万
2025-12-31
-$4344.8万
2025-09-30
-$4531.3万
有效税率
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
项目
2026-06-30
2026-03-31
2025-12-31
2025-09-30
营业收入
$0
$0
$0
$0
营业支出
$1909.6万
$2082万
$2328.4万
$2269.4万
净利润
-$2553.8万
$921.8万
-$4372.7万
-$4560.3万
净利润率
--
--
--
--
每股收益
$-0.12
$0.05
$-0.07
$-0.71
息税折旧摊销前利润
-$2526万
$949.9万
-$4344.8万
-$4531.3万
有效税率
--
--
--
--
常见问题
GUTS is a publicly traded stock ticker listed on a U.S. exchange. It represents a specific company, and its shares can be bought and sold during regular market hours. To understand what GUTS stock represents, investors should review the company's profile, business model, and financial disclosures available on the stock detail page. The ticker itself is simply an identifier used for trading and research purposes.
GUTS stock can be influenced by company-specific news such as earnings reports, product announcements, management changes, and strategic decisions. Broader market conditions, including economic data, interest rate expectations, and sector trends, can also affect its price. Additionally, investor sentiment, trading volume, and industry-specific developments may contribute to price movements. Monitoring these factors can help investors understand potential drivers of GUTS stock performance.
Recent performance of GUTS stock can be seen by reviewing its price changes over various time frames, such as daily, weekly, or monthly. The stock detail page provides up-to-date price information, including percentage changes and trading volume. For historical context, investors can compare current levels to previous closing prices and the 52-week range. Always refer to the latest data on the page for the most accurate performance figures.
Common valuation metrics for analyzing GUTS include the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio, depending on the company's industry and financial profile. Enterprise value multiples, such as EV/EBITDA, can also be relevant. These metrics help investors assess whether GUTS is trading at a premium or discount relative to its peers or historical averages. The stock detail page may provide some of these metrics.
Trading of GUTS stock outside regular market hours depends on whether it is eligible for pre-market or after-hours sessions. Many U.S. stocks can be traded during extended hours through certain brokers, but liquidity may be lower and spreads wider. The availability and rules for extended-hours trading can vary by brokerage. Investors should check with their broker and review the latest GUTS data on the page for any relevant trading information.
Investing in GUTS stock carries risks such as market volatility, company-specific operational challenges, and broader economic downturns. Sector-specific risks, competitive pressures, and regulatory changes can also impact performance. Financial risks, including debt levels and profitability, may affect the stock. Investors should review GUTS's risk factors in its regulatory filings and consider how these risks align with their investment objectives.